tert-Butyl ((S)-2-(3-bromophenyl)-1-((S)-oxiran-2-yl)ethyl)carbamate, 95.0%, 250mg

2-(2-Oxomorpholino)acetic acid, 95+%, 5g

5-Hydroxypiperidin-2-one, 97.0%, 5g

6-Bromo-1H-pyrrolo[3,2-b]pyridin-3-amine, 97%, 1g

N,N-Dicyclohexylcarbodiimide (DCC), 500 g, >=98%, glass packaging

tert-butyl N-(2-amino-1-cyclohexylethyl)carbamate, 95.0%, 500mg

Methyl 4-(dibromomethyl)-3-fluorobenzoate, 98%, 100mg

2,2'-Oxydiethanamine, 95.0%, 25g

3,4-Dihydro-5-hydroxy-1(2H)-isoquinolinone, 95.0%, 250mg

(R)-2-((R)-2-Amino-3-(1H-indol-3-yl)propanamido)-3-(1H-indol-3-yl)propanoic acid, 97.0%, 1g

1-Benzyl-4-(5-chloro-[1,2,4]thiadiazol-3-yl)-piperazine, 95.0%, 500mg

2-(2-aminoethyl)quinazolin-4(3H)-one dihydrochloride Hydrate, 95.0%, 5g

1-N,1-N-Diethyl-4-(trifluoromethyl)benzene-1,2-diamine, 1g